• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

muscular dystrophy - Articles and news items

FDA grants Santhera $246,000 for muscular dystrophy trial

Industry news / 30 August 2016 / Niamh Louise Marriott, Digital Content Producer

The FDA have granted Santhera an award of $246,000 in support of its ongoing Phase I trial with omigapil (callisto) incongenital muscular dystrophy (CMD)…


Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +